Annual Cash & Cash Equivalents
$2.62 M
-$7.50 M-74.13%
30 April 2024
Summary:
Champions Oncology annual cash & cash equivalents is currently $2.62 million, with the most recent change of -$7.50 million (-74.13%) on 30 April 2024. During the last 3 years, it has fallen by -$2.07 million (-44.14%). CSBR annual cash & cash equivalents is now -74.96% below its all-time high of $10.46 million, reached on 30 April 2011.CSBR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.89 M
+$274.00 K+10.47%
31 July 2024
Summary:
Champions Oncology quarterly cash and cash equivalents is currently $2.89 million, with the most recent change of +$274.00 thousand (+10.47%) on 31 July 2024. Over the past year, it has dropped by -$2.62 million (-47.54%). CSBR quarterly cash and cash equivalents is now -75.17% below its all-time high of $11.64 million, reached on 31 January 2023.CSBR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.1% | -47.5% |
| 3 y3 years | -44.1% | -39.5% |
| 5 y5 years | -19.1% | +3.9% |
CSBR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.1% | at low | -75.2% | +10.5% |
| 5 y | 5 years | -74.1% | at low | -75.2% | +10.5% |
| alltime | all time | -75.0% | >+9999.0% | -75.2% | >+9999.0% |
Champions Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $2.89 M(+10.5%) |
| Apr 2024 | $2.62 M(-74.1%) | $2.62 M(-41.4%) |
| Jan 2024 | - | $4.47 M(-19.0%) |
| Oct 2023 | - | $5.51 M(+13.2%) |
| July 2023 | - | $4.87 M(-51.9%) |
| Apr 2023 | $10.12 M(+12.3%) | $10.12 M(-13.1%) |
| Jan 2023 | - | $11.64 M(+7.6%) |
| Oct 2022 | - | $10.83 M(+34.4%) |
| July 2022 | - | $8.06 M(-10.5%) |
| Apr 2022 | $9.01 M(+92.2%) | $9.01 M(+3.5%) |
| Jan 2022 | - | $8.70 M(+82.0%) |
| Oct 2021 | - | $4.78 M(+19.6%) |
| July 2021 | - | $4.00 M(-14.7%) |
| Apr 2021 | $4.69 M(-43.8%) | $4.69 M(-36.9%) |
| Jan 2021 | - | $7.43 M(-13.1%) |
| Oct 2020 | - | $8.55 M(+23.2%) |
| July 2020 | - | $6.94 M(-16.8%) |
| Apr 2020 | $8.34 M(+157.7%) | $8.34 M(+154.2%) |
| Jan 2020 | - | $3.28 M(+17.9%) |
| Oct 2019 | - | $2.78 M(+26.4%) |
| July 2019 | - | $2.20 M(-32.0%) |
| Apr 2019 | $3.24 M(+278.2%) | $3.24 M(-2.2%) |
| Jan 2019 | - | $3.31 M(+69.2%) |
| Oct 2018 | - | $1.96 M(+92.5%) |
| July 2018 | - | $1.02 M(+18.7%) |
| Apr 2018 | $856.00 K(-74.0%) | $856.00 K(-19.4%) |
| Jan 2018 | - | $1.06 M(+60.9%) |
| Oct 2017 | - | $660.00 K(+53.5%) |
| July 2017 | - | $430.00 K(-86.9%) |
| Apr 2017 | $3.29 M(+27.5%) | $3.29 M(-5.5%) |
| Jan 2017 | - | $3.49 M(-19.4%) |
| Oct 2016 | - | $4.33 M(-3.0%) |
| July 2016 | - | $4.46 M(+72.6%) |
| Apr 2016 | $2.58 M(-72.4%) | $2.58 M(-21.5%) |
| Jan 2016 | - | $3.29 M(-20.8%) |
| Oct 2015 | - | $4.16 M(-38.5%) |
| July 2015 | - | $6.76 M(-27.8%) |
| Apr 2015 | $9.36 M(+58.8%) | $9.36 M(+5041.2%) |
| Jan 2015 | - | $182.00 K(-68.3%) |
| Oct 2014 | - | $575.00 K(-81.2%) |
| July 2014 | - | $3.05 M(-48.2%) |
| Apr 2014 | $5.89 M(-38.4%) | $5.89 M(+1.4%) |
| Jan 2014 | - | $5.81 M(-23.2%) |
| Oct 2013 | - | $7.57 M(+2.8%) |
| July 2013 | - | $7.37 M(-23.0%) |
| Apr 2013 | $9.56 M(+101.1%) | $9.56 M(-11.2%) |
| Jan 2013 | - | $10.77 M(+398.3%) |
| Oct 2012 | - | $2.16 M(-25.9%) |
| July 2012 | - | $2.92 M(-38.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2012 | $4.75 M(-54.5%) | $4.75 M(-26.7%) |
| Jan 2012 | - | $6.48 M(-8.9%) |
| Oct 2011 | - | $7.12 M(-19.5%) |
| July 2011 | - | $8.84 M(-15.5%) |
| Apr 2011 | $10.46 M(+306.6%) | $10.46 M(+255.6%) |
| Jan 2011 | - | $2.94 M(+132.9%) |
| Oct 2010 | - | $1.26 M(-39.5%) |
| July 2010 | - | $2.09 M(-18.8%) |
| Apr 2010 | $2.57 M(+48.8%) | $2.57 M(+73.9%) |
| Jan 2010 | - | $1.48 M(+275.4%) |
| Oct 2009 | - | $394.00 K(-74.2%) |
| July 2009 | - | $1.53 M(-11.5%) |
| Apr 2009 | $1.73 M(-53.4%) | $1.73 M(-34.2%) |
| Jan 2009 | - | $2.62 M(-14.0%) |
| Oct 2008 | - | $3.05 M(-12.7%) |
| July 2008 | - | $3.49 M(-5.8%) |
| Apr 2008 | $3.71 M(>+9900.0%) | $3.71 M(+245.8%) |
| Jan 2008 | - | $1.07 M(+193.1%) |
| Oct 2007 | - | $365.90 K(-27.8%) |
| July 2007 | - | $507.00 K(>+9900.0%) |
| Apr 2007 | $3800.00(+660.0%) | $3800.00(-81.7%) |
| Jan 2007 | - | $20.80 K(+5100.0%) |
| Oct 2006 | - | $400.00(-33.3%) |
| July 2006 | - | $600.00(+20.0%) |
| Apr 2006 | $500.00(-99.4%) | $500.00(-97.6%) |
| Jan 2006 | - | $21.00 K(-53.2%) |
| Oct 2005 | - | $44.90 K(-33.6%) |
| July 2005 | - | $67.60 K(-20.0%) |
| Apr 2005 | $84.50 K(-29.6%) | $84.50 K(+60.6%) |
| Jan 2005 | - | $52.60 K(-22.5%) |
| Oct 2004 | - | $67.90 K(-46.6%) |
| July 2004 | - | $127.10 K(+5.8%) |
| Apr 2004 | $120.10 K(-38.4%) | $120.10 K(+41.8%) |
| Jan 2004 | - | $84.70 K(-30.2%) |
| Oct 2003 | - | $121.40 K(-27.5%) |
| July 2003 | - | $167.40 K(-14.2%) |
| Apr 2003 | $195.10 K(-56.6%) | $195.10 K(-0.6%) |
| Jan 2003 | - | $196.30 K(-33.6%) |
| Oct 2002 | - | $295.60 K(-26.2%) |
| July 2002 | - | $400.30 K(-10.9%) |
| Apr 2002 | $449.30 K(-0.5%) | $449.30 K(+58.9%) |
| Jan 2002 | - | $282.80 K(-21.1%) |
| Oct 2001 | - | $358.50 K(-18.1%) |
| July 2001 | - | $437.70 K(-3.1%) |
| Apr 2001 | $451.60 K(-23.6%) | $451.60 K(+4.2%) |
| Jan 2001 | - | $433.50 K(-20.0%) |
| Oct 2000 | - | $541.70 K(-8.8%) |
| July 2000 | - | $594.20 K(+0.5%) |
| Apr 2000 | $591.20 K | $591.20 K(-15.5%) |
| Jan 2000 | - | $700.00 K |
FAQ
- What is Champions Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Champions Oncology?
- What is Champions Oncology annual cash & cash equivalents year-on-year change?
- What is Champions Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Champions Oncology?
- What is Champions Oncology quarterly cash and cash equivalents year-on-year change?
What is Champions Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of CSBR is $2.62 M
What is the all time high annual cash & cash equivalents for Champions Oncology?
Champions Oncology all-time high annual cash & cash equivalents is $10.46 M
What is Champions Oncology annual cash & cash equivalents year-on-year change?
Over the past year, CSBR annual cash & cash equivalents has changed by -$7.50 M (-74.13%)
What is Champions Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CSBR is $2.89 M
What is the all time high quarterly cash and cash equivalents for Champions Oncology?
Champions Oncology all-time high quarterly cash and cash equivalents is $11.64 M
What is Champions Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, CSBR quarterly cash and cash equivalents has changed by -$2.62 M (-47.54%)